Tweet
Our department is looking for a software solution to support analysis and reporting of somatic cancer variants (currently panels, but eventually exomes). It looks like most of the currently available reporting software (Cartagenia, Next Code) is designed to support germline analysis (rare disease analysis). We would be interested in any software packages that are available to specifically support somatic cancer variant analysis. Know of any?
-
-
Gerald -- I work at GenomOncology. We offer a Clinical Workbench, installed within your firewall, where the input is the BAM/VCF and QC files to enable professional interpretation (in a high-assurance fully traceable and audit-able manner) and generate a clinically actionable report in less than 20 minutes from start to finish. The report is template driven and 100% customizable to your labs needs.
Vanderbilt’s MyCancerGenome, plus FDA, NCCN and ACSO guidelines, drive the clinical interpretation and also allows the lab to add relevant Clinical Trials and content. We have an exclusive license for MyCancerGenome and a solid relationship with the Vanderbilt team. If your institution has its own rules, those can easily be added too.
Feel free to message me -- I'm happy to talk further. -
WuXi NextCODE support somatic cancer
Hi Gerald, I am with WuXi NextCODE. We do support somatic cancer. If you want a demo, please let me know. I am happy to walk you through it.Comment
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment